Expression of CD36 in Macrophages and Atherosclerosis The Role of Lipid Regulation of PPARγ Signaling

Trends in Cardiovascular Medicine

Volumn 14, Issue 1, 2004, Pages 8-12

  Nicholson, Andrew C ^a,b  

^a Weill Cornell Medical College of Cornell University   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; LIPID; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR;

ANTIGEN EXPRESSION; ATHEROSCLEROSIS; CELL MATURATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; HUMAN; MACROPHAGE; MOLECULAR BIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSPORT KINETICS; VASCULAR DISEASE;

EID: 0346056965     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.09.004     Document Type: Review

References (42)

1. Acton S., Attilio R., Landschultz Ket al. Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science. 271:1996;518-520.
2. Adams M., Reginato J., Shao Det al. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated kinase site. J Biol Chem. 272:1997;5128-5132.
3. Boullier A., Gillotte K.L., Horkko Set al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem. 275:2000;9163-9169.
4. Calvo D., Vega M.A. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem. 268:1993;18,929-18,935.
5. Calvo D., Gomez-Coronado D., Suarez Yet al. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res. 39:1998;777-788.
6. Camp H.S., Tafuri S.R. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J Biol Chem. 272:1997;10,811-10,816.
7. Chawla A., Barak Y., Nagy Let al. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med. 7:2001;48-52.
8. Chen Z., Ishibashi S., Perrey Set al. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol. 21:2001;372-377.
9. Chinetti G., Lestavel S., Bocher Vet al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med. 7:2001;53-58.
10. Collins A.R., Meehan W.P., Kintscher Uet al. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 21:2001;365-371.
11. Connelly M.A., Klein S., Azhar Set al. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem. 274:1999;41-47.
12. Endemann G., Stanton L., Madden Ket al. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11,811-11,816.
13. Febbraio M., Abumrad N.A., Hajjar DPet al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 274:1999;19,055-19,062.
14. Febbraio M., Podrez E.A., Smith JDet al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 105:2000;1049-1056.
15. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angioigenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 108:2001;785-791.
16. Han J., Hajjar D.P., Febbraio Met al. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 272:1997;21,654-21,659.
17. Han J., Hajjar D.P., Tauras JMet al. Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. J Lipid Res. 40:1999;830-838.
18. Han J., Hajjar D.P., Tauras JMet al. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem. 275:2000;1241-1246.
19. Han J., Hajjar D.P., Zhou Xet al. Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem. 277:2002;23,582-23,586.
20. Huang J.T., Welch J.S., Ricote Met al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by12/15-lipoxygenase. Nature. 400:1999;378-382.
21. Huh H-Y, Pearce S.F.A., Yesner Let al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 87:1996;2020-2028.
22. Kashiwagi H., Tomiyama Y., Kosugi Yet al. Identfication of the molecular defects in a subject with type I CD36 deficiency. Blood. 83:1994;3545-3552.
23. Kunjathoor V.V., Febbraio M., Podrez EAet al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 277:2002;49,982-49,988.
24. Li A.C., Brown K.K., Silvestre MJet al. Peroxisome proliferator- activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 106:2000;523-531.
25. Li Y.S., Shyy Y.J., Wright JGet al. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol Cell Biochem. 126:1993;61-68.
26. Lin K.H., Ashizawa K., Cheng S.Y. Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone nuclear receptor. Proc Natl Acad Sci USA. 89:1992;7737-7741.
27. Lougheed M., Lum C., Ling Wet al. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem. 272:1997;12,938-12,944.
28. Moore K.J., Rose E.D., Fitzgerald MLet al. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med. 7:2001;41-47.
29. Nagy L., Tontonoz P., Alvarez Jet al. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell. 93:1998;229-240.
30. Nakagawa T., Nozaki S., Nishida Met al. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 18:1998;1350-1357.
31. Nakata A., Nakagawa Y., Nishida Met al. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol. 19:1999;1333-1339.
32. Nicholson A., Pearce S.F.A., Silverstein R. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol. 15:1995;269-275.
33. Nozaki S., Kashiwagi H., Yamashita Set al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 96:1995;1859-1865.
34. Parthasarathy S., Fong L., Otero Det al. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc Natl Acad Sci USA. 84:1987;537-540.
35. Podrez E.A., Febbraio M., Sheibani Net al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest. 105:2000;1095-1108.
36. Podrez E.A., Poliakov E., Shen Zet al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem. 277:2002;38,503-38,516.
37. Ricote M., Li A., Wilson Tet al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
38. Rigotti A., Acton S., Krieger M. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J Biol Chem. 270:1995;16,221-16,224.
39. Tontonoz P., Hu E., Spiegelman B. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev. 5:1995;571-576.
40. Tontonoz P., Nagy L., Alvarez Jet al. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
41. Xue J.C., Schwarz E.J., Chawla Aet al. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma. Mol Cell Biol. 16:1996;1567-1575.
42. Yesner L., Huh H., Pearce SFAet al. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol. 16:1996;1019-1025.